Martine Zimmermann Receives Stock Award at Candel Therapeutics Inc (CADL) — SEC Form 4, Sep 10, 2026

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
Martine Zimmermann
Director
TXN 2026-09-08 · FILED 2026-09-10
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Candel Therapeutics Inc

CADL CIK 0001841387
All Candel Therapeutics Inc insider activity
Filing Date
2026-09-10
Report Date
2026-09-10
Accession No.
0001193125-26-387924
Accepted At
2026-09-10 20:24 UTC
Reporting Owner
Name Relationship
Martine Zimmermann CIK 0001994049
Director
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Stock Option (Right to Buy)F1 $12.60 2026-09-08 A - Award/Grant 64,000 A $0.00 2036-09-08 64,000 Common Stock Direct
Footnotes (1)
F1
The shares underlying this option shall vest and become exercisable in thirty-six (36) equal monthly installments, subject to the Reporting Person's continued service on each such vesting date. Show more

Related filings at Candel Therapeutics Inc

Institutional Holders
13F holders · Jun 30, 2026 137 institutional managers reporting a position
Largest by reported value
  1. Fmr Llc $113M
  2. Rtw Investments, Lp $66.1M
  3. Black Rock, Inc. $51.2M
5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Candel Therapeutics Inc
All Candel Therapeutics Inc insider activity
GET /v1/forms/4/0001193125-26-387924 API docs
View Original SEC Filing